Abstract
Cutaneous necrotizing vasculitis (CNV) is a complex multisystem disease generally involving the skin and mucous membranes, often accompanied by renal, gastrointestinal, pericardial, neurological, and articular signs and symptoms. CNV may be idiopatical or occur in association with a drug, infection, or underlyng disease.
CNV has been shown in patients with chronic infections (viral, bacterial, protozoa, helminthic), serum sickness, a variety of collagen vascular diseases (systemic lupus erythematous, Sjögren’s syndrome, rheumatoid arthritis, Behçet’s disease) hyperglobulinemic states, cryoglobulinemia, bowel bypass syndrome, ulcerative colitis, cystic fibrosis, primary biliary cirrhosis and HIV infection. Association with malignancies is not frequent. Lympho- proliferative disorders (Hodgkin’s disease, mycosis fungoides, lymphosarcoma, adult T-cell leukemia, multiple mieloma) and solid tumors (lung cancer, colon carcinoma, renal, prostate, head and neck cancer and breast cancer) may be associated with CNV Whenever possible, treatment is directed at the elimination of the cause. In other cases after adequate laboratory screening local and systemic therapy are recommended.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lotti T, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Int J Dermatol 35: 457–474. 1996.
Ryan TJ. Cutaneous vasculitis. In: Rook A, et al, eds. Textbook of Dermatology. Oxford: Blackwell Sc Publ, 1893–1961. 1992.
Comacchi C, Ghersetich I, Lotti T. La vasculite necrotizzante cutanea. G Ital Dermatol Venereol 1998. In press.
Lotti T, Ghersetich I, Comacchi C, Panconesi E. Purpuras and related conditions. J Eur Acad Dermatol Venereol, 7–25. 1996
Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous small vessel vasculitis. Am Acad Dermatol 1998. In press.
Jorizzo JL, Solomon AR, Zanolli MD, et al. Neutrophilic vascular reactions. J Am Acad Dermatol. 19(6): 983–1005. 1988
Soter NA, Wolff SM. Necrotizing vasculitis. In: Fitzpatrick TB, et al, eds. Dermatology in General Medicine. New York: McGraw-Hill Book Company. 1300–1312. 1987
Soter NA, Mihm MC Jr, Gigli I, et al. Two distinct cellular patterns in cutaneous necrotizing angiitis. J Invest Dermatol. 66: 344–350. 1976
Ghersetich I, Campanile G, Comacchi C, et al. Cutaneous necrotizing vasculitis: are there indeed two distinct histopathological entities? Abstract Book “14th Colloquium of the International Society of Dermopathology”, Siena, 26 June–1 July 1993. 86.
Ghersetich I, Campanile G, Comacchi C, Lotti T. Immunohistochemical and ultrastructural aspects of leukocytoclastic cutaneous necrotizing vasculitis (CNV). J Invest Dermatol 100(4): 545. 1993.
Ghersetich I, Comacchi C, Lotti T. La vasculite cutanée nécrosante: l’infiltrat cellulaire et l’expression de quelques récepteurs de molécules d’adhesion. Nouv Dermatol. 11(10): 852–853. 1992
Ghersetich I, Campanile G, Comacchi C, Lotti T. The cell-mediated pathway in the pathogenesis of the leukocytoclastic form of cutaneous necrotizing vasculitis.Abstract Book “Dermatology 2000”, Vienna 18–21 May 1993. 271.
Comacchi C, Ghersetich I, Lotti T. Una cellula ememergente in dermatologia: il linfocita T gamma/delta. G Ital Dermatol Venereol. 128(4): 133–40. 1993
Campanile G, Comacchi C, Ghersetich I, Lotti T. Gamma/delta T lymphocytes in cutaneous necrotizing vasculitis. Int Angiol 14(2): 119–124. 1995.
Ghersetich I, Campanile G, Comacchi C, Lotti T. Gamma/delta TCR lymphocytes in cutaneous necrotizing vasculitis (CNV): a clue to the infective etiology. J Invest Dermatol. 100(4): 465. 1993
Parish WE. Studies on vasculitis. Immunoglobulins, B1C, C-reactive protein, and bacterial antigens in cutaneous vasculitis lesions. Clin Allergy. 1: 97–109. 1971
Gower RG. Small vessel vasculitis caused by hepatitis B virus immune complexes: small vessel vasculitis and HBsAG. J Allergy Clin Immunol. 62: 222. 1978.
Thorne EG, Gower R, Claman HN. Hepatitis B surface antigen and leukocytoclastic vasculitis. J Invest Dermatol. 68: 243–247. 1977
Heart-Holmes M, Zahradka S, Baethge BA, et al. Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 90: 765–766. 1991.
Dan M, Yaniv R. Cholestatic hepatitis, cutaneous vasculitis and vascular deposits of immunoglobulin M and complement associated with hepatitis A virus infection. Am J Med 89: 103–104. 1990.
Mosovich B, Biton A, Avinoach I. Vasculitis with cutaneous necrosis induced by oral contraceptive. Harefuah. 120: 451–453. 1991
Patel A, Prussick R, Buchanan WW. Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol 1991. 24: 652–653.
Parker CW. Drug allergy. In: Parker CW, ed. Clinical Immunology. Philadelphia: Saunders WB Company, 1219–1260. 1980.
Berman BA, Ross RN. Acute serum sickness. Cutis 32: 420–422. 1983
Vial T, Laine V, Delcombel M, et al. Vasculitis after anti-influenza vaccination. Report of 5 cases. Therapie 45: 509–512. 1990.
Drago F, Arditi M, Rebora A. Tamoxifen and purpuric vasculitis. Ann Intern Med 112: 965–966. 1990.
Hodge SJ, Callen JP, Ekenstom E. Cutaneous leukocytoclastic vasculitis: correlation of histopathological changes with clinical severity and course. J Cutan Pathol. 14: 279–284. 1987
Lakhanpal S, Conn DL, Lie JT. Clinical and prognostic significance of vasculitis as an early manifestation of connective tissue disease syndrome. Ann Intern Med 101: 743–748. 1984.
Estes D, Christian DL. The natural history of systemic lupus erythematous by prospective analysis. Medicine. 50: 85–95. 1971
Dubois EL, Wallace DJ. Clinical and laboratory manifestations of systemic lupus erythematosus. In: Wallace DJ, et al, eds. Lupus erythematosus. Philadelphia: Lea and Febriger. 317–449. 1987
Chevalier X, Belmatoug N, Kahn MF. Seronegative leukocytoclastic vasculitis preceding the onset of disseminated systemic lupus erythematosus. Rev Rhum Mal Osteoartic 57: 779–783. 1990.
O’ Loughlin, Schroeter AL, Jordan RE. Chronic urticaria — like lesions in systemic lupus erythematosus. Arch Dermatol. 114: 879–883. 1978
Christian CL, Sergent JJ. Vasculitis syndromes: clinical and experimental models. Am J Med. 61: 385–392. 1976
Lawley TJ, Moutsopoulos HM, Katz SI, et al. Demonstration of circulating immune complexes in Sjogren’s syndrome. J Immunol. 123: 1382–1387. 1979
Moutsopoulos HM, Chused TM, Mann DL, et al. Sjogren’s syndrome (sicca syndrome): current issues. Ann Intern Med. 92: 212–226. 1980
Talal N, Moutsopoulos HM, Kassan SS. Sjögren Syndrome. Clinical and immunological aspects. Berlin: Springer, 1987.
Gray RG, Poppo MJ. Necrotizing vasculitis as the initial manifestation of rheumatoid arthritis. J Rheumatol 10: 326–328. 1983
Nishikawa JA. Are leg ulcers in rheumatoid arthritis due to vasculitis? Eur J Rheum Inflam. 6: 288–290. 1983
Jorizzo JL, Daniels JC. Dermatologic conditions reported in patients with rheumatoid arthritis. J Am Acad Dermatol. 8: 439–457. 1983
Levinsky RJ, Lehner J. Circulating soluble immune complexes in recurrent oral ulceration and Behçet’ syndrome. Clin Exp Immunol. 32: 193–198. 1978
Valesini G, Picardo M, Pastare R et al. Circulating immune complexes in Behçet’s syndrome: purification, characterization and cross reactivity studies. Clin Exp Immunol. 44: 522–527. 1981
Jorizzo J. Behçet’s disease. An update based on the 1985 international conference in London. Arch Dermatol. 122: 556–558. 1986
Waldenström J. Dysproteinemias. In: Fitzpatrick TB, et al, eds. Dermatology in General Medicine. New York: McGraw-Hill Book Company. 1650–1654. 1987
Braun-Falco O, Plewig G, Wolff HH, et al. Dermatology. Berlin Heidelberg: Springer-Verlag. 877–878. 1991
Boom BW, Brand A, Bouwes-Bavink JN, et al. Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose gamma-globulins intravenously. Arch Dermatol. 124: 1550–1553. 1988
Bronet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulinemia: a report of 86 cases. Am J Med. 57: 775–788. 1974
Popp JW Jr, Dienstag JL, Wands JR, et al. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med. 92: 379–383. 1980
Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol. 2: 473–487. 1980
Dicken CH, Seehafter JR. Bowel bypass syndrome. Arch Dermatol. 115: 837–839. 1979
Gilliam JN, Smiley JD. Cutaneous necrotizing vasculitis and related disorders. Ann Allergy. 37: 328–339. 1976
Webb AK. Management problems of the adult with cystic fibrosis. Schweiz Med Wochenschr. 121: 110–114. 1991
Soter NA et al. Cutaneous necrotizing venulitis in patients with cystic fibrosis. J Pediatr. 95: 197. 1979
Weimer Ce Jr, Sahn EE. Follicular accentuation of leukocytoclastic vasculitis in an HIV-seropositive man. Report of a case and review of the literature. J Am Acad Dermatol. 24: 898–902. 1991
Cockerell CJ. Noninfectious inflammatory skin diseases in HIV-infected individuals. Dermatol Clin. 9: 531–541. 1991
Barlow RJ, Schulz EJ. Necrotizing folliculitis in AIDS-related complex. Br J Dermatol. 116: 581–584. 1987
Kurzrock R, Cohen PR. Vasculitis and Cancer. Clinics in Dermatology. 11; 175–187. 1993
Greer JM, Lousley S, Edwards NL, et al. Vasculitis associated with malignancy. Medicine. 67: 220–229. 1988
Nevin M, Armus S, Wolff M, et al. Cutaneous T-cell lymphoma in association with leukocytoclastic vasculitis. Int J Dermatol. 30: 443–444. 1991
Kesseler ME, Slater DN. Cutaneous vasculitis: A presenting feature in Hodgkin’s disease. J R Soc Med. 79: 485–486. 1986
Sams WM Jr, Harville DD, Winkelmann RK. Necrotizing vasculitis associated with lethal reticuloen-dothelial diseases. Br J Dermatol. 80: 555–560. 1968
Kois JM, Sexton FM, Lookingbill DP. Cutaneous manifestations of multiple myeloma. Arch Dermatol. 127: 69–74. 1991
Beylot J, Malou M, Doutre MS, et al. Leukocytoclastic vasculitis and malignant hematologic diseases (12 cases). Rev Med Interne. 10: 509–514. 1989
Callen JR Cutaneous leukocytoclastic vasculitis in a patient with an adenocarcinoma of the colon. J Rheumatol.14: 386–389. 1987
Lewis JE. Urticarial vasculitis occurring in association with visceral malignancy. Acta Derm Venereol (Stockh). 70: 344–345. 1990
Saulsbury FT. Henoch-Schöenlein purpura. Pediatr Dermatol. 1: 195–201. 1984
Palier AS. Disorders of the immune system. In: Schachner LA, et al, eds. Pediatric Dermatology. New York: Churchill Livingstone Inc. 93–137. 1988
Heng MCY. Henoch-Schöenlein purpura. Br J Dermatol. 112: 235–240. 1985
VanHale HM, Gibson LE, Schroeter AL. Henoch-Schöelein vasculitis: direct immunefluorescence study of uninvolved skin. J Am Acad Dermatol. 15: 665–670. 1986
Stevenson JA, Leong LA, Cohen AH, et al. Henoch-Schönleinpurpura. Simultaneous demonstration of IgA deposits in involved skin, intestine, and kidney. Arch Pathol 106: 192–195. 1982
Soter NA. Chronic urticaria as a manifestation of necrotizing venulitis. N Engl J Med. 296: 1440–1442. 1977
Wanderer AA, Nuss DD, Thormey AD, et al. Urticarial leukocytoclastic vasculitis with cold urticarial: report of a case and review of the literature. Arch Dermatol. 119: 145–151. 1983
Monroe EF. Urticarial vasculitis: an update review. J Am Acad Dermatol. 5: 88–95. 1981
Callen JP, Kalbfleisch S. Urticarial vasculitis: a report of nine cases and review of the literature. Br J Dermatol. 107: 87–94. 1982
Scherer R. Urtikariavaskulitis. Hautarzt. 36(suppl VII): 48–50. 1985
Borradori L et al. Urticarial vasculitis associated with monoclonal IgM gammopathy: Schnitzler’s syndrome. Br J Dermatol 123: 113–118. 1990.
Grassegger A, Greil R, Feichtinger J, et al. Urticarial vasculitis as a symptom of Muckle-Wells syndrome? Hautarzt. 42: 116–119. 1991
Cream JJ, Leven GM, Calnan CD. Erythema elevatum diutinum. Br J Dermatol. 84: 393–399. 1971
Le Boit PE, Yen TSB, Wintroub B. The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol. 8: 392–402. 1986
Wolff HH, Scherer R, Maciejewski W, et al. Erythema elevatum diutinum. II. Immunoelectromicroscopical study of leukocytoclastic vasculitis within the intracutaneous test reaction induced by streptococcal antigen. Arch Dermatol Res. 261: 17–26. 1978
Feldacker M, Hines EA, Kierland RR. Livedo reticularis with summer ulcerations. Arch Dermatol Syphilol. 72: 31–37. 1955
Marsch WC, Muckelmann R. Generalized racemose livedo with cerebrovascular lesions (Sneddon syndrome): an occlusive arteriolopathy due to proliferation and migration of medial smooth muscle cells. Br J Dermatol. 112: 703–708. 1985
Braun Falco O, Plewig G, Wolff HH, et al. Dermatology. Berlin: Springer-Verlag. 637–638. 1991
Diaz-Perez J, Winkelmann RK. Cutaneous periarteritis nodosa. Arch Dermatol. 110: 407–412. 1974
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lotti, T.M., Comacchi, C., Ghersetich, I. (1999). Cutaneous Necrotizing Vasculitis. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4857-7_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7203-5
Online ISBN: 978-1-4615-4857-7
eBook Packages: Springer Book Archive